AbbVie (ABBV) Change in Acquisitions & Divestments (2012 - 2025)

AbbVie (ABBV) has reported Change in Acquisitions & Divestments for 14 consecutive years, with $34.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments fell 12.82% year-over-year to $34.0 million; the TTM figure through Dec 2025 stood at $76.0 million (down 86.31% YoY), while the FY2025 annual figure was $76.0 million, down 86.31% from the prior year.
• Change in Acquisitions & Divestments grew to $34.0 million in Q4 2025 per ABBV's latest filing, from $3.0 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $1.4 billion in Q3 2022 and bottomed at $3.0 million in Q2 2024.
• Historically, Change in Acquisitions & Divestments has averaged $115.7 million across 5 years, with a median of $18.0 million in 2023.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments sank 99.65% — and 2024, when it soared 10040.0%.
• AbbVie's Change in Acquisitions & Divestments stood at $10.0 million in 2021, then surged by 600.0% to $70.0 million in 2022, then tumbled by 80.0% to $14.0 million in 2023, then surged by 178.57% to $39.0 million in 2024, then fell by 12.82% to $34.0 million in 2025.
• Business Quant data shows ABBV's Change in Acquisitions & Divestments at $34.0 million in Q4 2025, $3.0 million in Q3 2025, and $7.0 million in Q2 2025.